BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 11507038)

  • 1. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns.
    Gruvberger S; Ringnér M; Chen Y; Panavally S; Saal LH; Borg A ; Fernö M; Peterson C; Meltzer PS
    Cancer Res; 2001 Aug; 61(16):5979-84. PubMed ID: 11507038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways.
    Yang F; Foekens JA; Yu J; Sieuwerts AM; Timmermans M; Klijn JG; Atkins D; Wang Y; Jiang Y
    Oncogene; 2006 Mar; 25(9):1413-9. PubMed ID: 16261164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.
    Yu K; Ganesan K; Miller LD; Tan P
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3288-96. PubMed ID: 16740749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
    Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
    J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in projecting clustering results across gene expression-profiling datasets.
    Lusa L; McShane LM; Reid JF; De Cecco L; Ambrogi F; Biganzoli E; Gariboldi M; Pierotti MA
    J Natl Cancer Inst; 2007 Nov; 99(22):1715-23. PubMed ID: 18000217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor.
    Levenson AS; Svoboda KM; Pease KM; Kaiser SA; Chen B; Simons LA; Jovanovic BD; Dyck PA; Jordan VC
    Cancer Res; 2002 Aug; 62(15):4419-26. PubMed ID: 12154049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
    Balasenthil S; Barnes CJ; Rayala SK; Kumar R
    FEBS Lett; 2004 Jun; 567(2-3):243-7. PubMed ID: 15178330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
    Kinoshita Y; Chen S
    Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles.
    Cunliffe HE; Ringnér M; Bilke S; Walker RL; Cheung JM; Chen Y; Meltzer PS
    Cancer Res; 2003 Nov; 63(21):7158-66. PubMed ID: 14612509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of estrogen on global gene expression: identification of novel targets of estrogen action.
    Charpentier AH; Bednarek AK; Daniel RL; Hawkins KA; Laflin KJ; Gaddis S; MacLeod MC; Aldaz CM
    Cancer Res; 2000 Nov; 60(21):5977-83. PubMed ID: 11085516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting features of breast cancer with gene expression patterns.
    Lu X; Lu X; Wang ZC; Iglehart JD; Zhang X; Richardson AL
    Breast Cancer Res Treat; 2008 Mar; 108(2):191-201. PubMed ID: 18297396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
    Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
    Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
    Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
    Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct promoter usage of mdm2 gene in human breast cancer.
    Okumura N; Saji S; Eguchi H; Nakashima S; Saji S; Hayashi S
    Oncol Rep; 2002; 9(3):557-63. PubMed ID: 11956627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genomic profile of HER2-amplified breast cancers: the influence of ER status.
    Marchiò C; Natrajan R; Shiu KK; Lambros MB; Rodriguez-Pinilla SM; Tan DS; Lord CJ; Hungermann D; Fenwick K; Tamber N; Mackay A; Palacios J; Sapino A; Buerger H; Ashworth A; Reis-Filho JS
    J Pathol; 2008 Dec; 216(4):399-407. PubMed ID: 18810758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
    Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
    J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentially expressed genes and estrogen receptor status in breast cancer.
    Nagai MA; Ros N; Bessa SA; Mourão Neto M; Miracca EC; Brentani MM
    Int J Oncol; 2003 Nov; 23(5):1425-30. PubMed ID: 14532986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.
    Oh DS; Troester MA; Usary J; Hu Z; He X; Fan C; Wu J; Carey LA; Perou CM
    J Clin Oncol; 2006 Apr; 24(11):1656-64. PubMed ID: 16505416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of gene transcript signatures predictive for estrogen receptor and lymph node status using a stepwise forward selection artificial neural network modelling approach.
    Lancashire LJ; Rees RC; Ball GR
    Artif Intell Med; 2008 Jun; 43(2):99-111. PubMed ID: 18420392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.